piracetam has been researched along with Adenoma Sebaceum in 3 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
Adenoma Sebaceum: Facial ANGIOFIBROMA in tuberous sclerosis
| Excerpt | Relevance | Reference |
|---|---|---|
| "Levetiracetam appears to be effective in treatment-resistant seizures which are symptomatic to tuberous sclerosis when used adjunctively as well as in monotherapy." | 7.74 | Tuberous sclerosis successfully treated with levetiracetam monotherapy: 18 months of follow-up. ( Myrianthopoulou, P; Papacostas, SS; Papathanasiou, ES; Stylianidou, G, 2007) |
| "Levetiracetam was generally well tolerated, and adverse events were relatively uncommon in patients who responded to treatment." | 5.33 | Levetiracetam as adjunctive antiepileptic therapy for patients with tuberous sclerosis complex: a retrospective open-label trial. ( Chuck, G; Collins, JJ; Franz, DN; Leonard, JM; Tudor, C, 2006) |
| "Levetiracetam appears to be effective in treatment-resistant seizures which are symptomatic to tuberous sclerosis when used adjunctively as well as in monotherapy." | 3.74 | Tuberous sclerosis successfully treated with levetiracetam monotherapy: 18 months of follow-up. ( Myrianthopoulou, P; Papacostas, SS; Papathanasiou, ES; Stylianidou, G, 2007) |
| "Tuberous sclerosis or Tuberous Sclerosis Complex (TSC) is a genetic disorder characterized by the growth of numerous benign tumours in many parts of the body caused by mutations on either of two genes, TSC1 and TSC2." | 1.36 | Tuberous sclerosis. ( Syed, KN, 2010) |
| "Levetiracetam was generally well tolerated, and adverse events were relatively uncommon in patients who responded to treatment." | 1.33 | Levetiracetam as adjunctive antiepileptic therapy for patients with tuberous sclerosis complex: a retrospective open-label trial. ( Chuck, G; Collins, JJ; Franz, DN; Leonard, JM; Tudor, C, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Syed, KN | 1 |
| Collins, JJ | 1 |
| Tudor, C | 1 |
| Leonard, JM | 1 |
| Chuck, G | 1 |
| Franz, DN | 1 |
| Papacostas, SS | 1 |
| Papathanasiou, ES | 1 |
| Myrianthopoulou, P | 1 |
| Stylianidou, G | 1 |
3 other studies available for piracetam and Adenoma Sebaceum
| Article | Year |
|---|---|
Tuberous sclerosis.
Topics: Adult; Anticonvulsants; Carbamazepine; Female; Humans; Levetiracetam; Mutation; Piracetam; Tuberous | 2010 |
Levetiracetam as adjunctive antiepileptic therapy for patients with tuberous sclerosis complex: a retrospective open-label trial.
Topics: Adolescent; Adult; Anorexia; Anticonvulsants; Behavioral Symptoms; Child; Child, Preschool; Dose-Res | 2006 |
Tuberous sclerosis successfully treated with levetiracetam monotherapy: 18 months of follow-up.
Topics: Anticonvulsants; Child; Follow-Up Studies; Humans; Levetiracetam; Male; Piracetam; Seizures; Tuberou | 2007 |